Phase 1/2 study of immunotherapy with dendritic cells pulsed with autologous tumor lysate in patients with refractory bone and soft tissue sarcoma

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862 · see citing works

IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE

Steinman, R. M., & Cohn, Z. A. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.137.5.1142 · Cited by 2,443 · see citing works

Taking dendritic cells into medicine

Steinman, R., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,243 · see citing works

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

van der Graaf, W. T. A., Blay, J., Chawla, S. P., Kim, D., Bui-Nguyen, B., Casali, P. G., Schöffski, P., Aglietta, M., Staddon, A. P., Beppu, Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60651-5 · Cited by 2,103 · see citing works

Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804 · see citing works

Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

Thurner, B., Haendle, I., Röder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., Driesch, P. V. D., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1669 · Cited by 1,226 · see citing works

The immunosuppressive tumour network: myeloid‐derived suppressor cells, regulatory T cells and natural killer T cells

Lindau, D., Gielen, P. R., Kroesen, M., Wesseling, P., & Adema, G. J. (2012) · Immunology · doi:10.1111/imm.12036 · Cited by 817 · see citing works

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Hogendoorn, P. C. W., Athanasou, N. A., Bielack, S., de Álava, E., Tos, A. P. D., Ferrari, S., Gelderblom, H. A. J., Grimer, R. J., Hall, K. S., Hassan, A. B., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq223 · Cited by 716 · see citing works

Clinical use of dendritic cells for cancer therapy

Anguille, S., Smits, E., Lion, E., Tendeloo, V. F. V., & Berneman, Z. N. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70585-0 · Cited by 707 · see citing works

Immune escape of tumors: apoptosis resistance and tumor counterattack

Igney, F. H., & Krammer, P. H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.6.907 · Cited by 468 · see citing works

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells

Dhodapkar, M. V., Steinman, R. M., Sapp, M., Desai, H., Fossella, C., Krasovsky, J., Donahoe, S. M., Dunbar, P. R., Cerundolo, V., Nixon, D. F., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6909 · Cited by 467 · see citing works

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial

Grignani, G., Palmerini, E., Ferraresi, V., D’Ambrosio, L., Bertulli, R., Asaftei, S. D., Tamburini, A., Pignochino, Y., Sangiolo, D., Marchesi, E., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71136-2 · Cited by 339 · see citing works

Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study

Kawai, A., Araki, N., Sugiura, H., Ueda, T., Yonemoto, T., Takahashi, M., Morioka, H., Hiraga, H., Hiruma, T., Kunisada, T., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70098-7 · Cited by 217 · see citing works

Natural Killer Cell IFN-γ Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor–Bearing Patients

Ménard, C., Blay, J.-Y., Borg, C., Michiels, S., Ghiringhelli, F., Robert, C., Nonn, C., Chaput, N., Taïeb, J., Delahaye, N. F., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3807 · Cited by 202 · see citing works

Immunologic response to cryoablation of breast cancer

Sabel, M. S., Nehs, M. A., Su, G., Lowler, K. P., Ferrara, J. L. M., & Chang, A. E. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-3289-1 · Cited by 189 · see citing works

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas

Okada, H., Lieberman, F. S., Walter, K. A., Lunsford, L. D., Kondziolka, D. S., Bejjani, G. K., Hamilton, R. L., Torres-Trejo, A., Kaliński, P., Cai, Q., et al. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-67 · Cited by 130 · see citing works

Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Children's Research Hospital experience

Leary, S. E. S., Wozniak, A. W., Billups, C. A., Wu, J., McPherson, V., Neel, M. D., Rao, B. N., & Daw, N. C. (2013) · Cancer · doi:10.1002/cncr.28111 · Cited by 129 · see citing works

Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients

Prins, R. M., Wang, X., Soto, H., Young, E., Lisiero, D. N., Fong, B., Everson, R. G., Yong, W. H., Lai, A., Li, G., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182811ae4 · Cited by 124 · see citing works

The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study

Nakamura, T., Matsumine, A., Kawai, A., Araki, N., Goto, T., Yonemoto, T., Sugiura, H., Nishida, Y., Hiraga, H., Honoki, K., et al. (2016) · Cancer · doi:10.1002/cncr.29961 · Cited by 123 · see citing works

Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state

Fujimoto, T., Duda, R. B., Szilvasi, A., Chen, X., Mai, M., & O’Donnell, M. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5619 · Cited by 118 · see citing works

Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model

Murakami, T., DeLong, J. C., Eilber, F. C., Zhao, M. D., Zhang, Y., Zhang, N., Singh, A. S., Russell, T. A., Deng, S., Reynoso, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7226 · Cited by 116 · see citing works

Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas

Merchant, M. S., Bernstein, D. B., Amoako, M. O., Baird, K., Fleisher, T. A., Morre, M., Steinberg, S. M., Sabatino, M., Stroncek, D. F., Venkatasan, A. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2550 · Cited by 112 · see citing works

High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model

Kiyuna, T., Murakami, T., Tome, Y., Kawaguchi, K., Igarashi, K., Zhang, Y., Zhao, M. D., Li, Y., Bouvet, M., Kanaya, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8848 · Cited by 97 · see citing works

Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response

Hus, I., Schmitt, M. W., Tabarkiewicz, J., Radej, S., Wojas‐Krawczyk, K., Bojarska-Junak, A. A., Schmitt, A., Giannopoulos, K., Dmoszyńska, A., & Roliński, J. (2008) · Leukemia · doi:10.1038/leu.2008.29 · Cited by 89 · see citing works

A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma

Poschke, I. C., Lövgren, T., Adamson, L., Nystrom, M. L., Andersson, E. K., Hansson, J., Tell, R., Masucci, G. V., & Kiessling, R. W. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1575-2 · Cited by 76 · see citing works

Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma

Himoudi, N., Wallace, R., Parsley, K. L., Gilmour, K., Barrie, A.-U., Howe, K., Dong, R., Sebire, N. J., Michalski, A., Thrasher, A. J., et al. (2012) · Clinical and Translational Oncology · doi:10.1007/s12094-012-0795-1 · Cited by 74 · see citing works

Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients

Reyes, D., Salazar, L., Espinoza, E., Pereda, C., Castellón, E. A., Valdevenito, R., Huidobro, C., Becker, M. I., Lladser, Á., López, M. N., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.494 · Cited by 64 · see citing works

Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization

Nakamoto, Y., Mizukoshi, E., Kitahara, M., Arihara, F., Sakai, Y., Kakinoki, K., Fujita, Y., Marukawa, Y., Kazumori, A. R. A. I., Yamashita, T., et al. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04246.x · Cited by 60 · see citing works

Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients

Caballero‐Baños, M., Benítez‐Ribas, D., Tabera, J., Varea, S., Vilana, R., Bianchi, L., Ayuso, J. R., Pagés, M., Carrera, G., Cuatrecasas, M., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.06.008 · Cited by 57 · see citing works

Therapeutic Dendritic Cell Vaccination of Patients with Renal Cell Carcinoma

Berntsen, A., Geertsen, P. F., & Svane, I. M. (2006) · European Urology · doi:10.1016/j.eururo.2006.03.061 · Cited by 56 · see citing works

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma

Shimizu, K., Kotera, Y., Aruga, A., Takeshita, N., Katagiri, S., Ariizumi, S., Takahashi, Y., Yoshitoshi, K., Takasaki, K., & Yamamoto, M. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27678 · Cited by 55 · see citing works

Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use

Kuroki, H., Morisaki, T., Matsumoto, K., Onishi, H., Baba, E., Tanaka, M., & Katano, M. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0394-7 · Cited by 53 · see citing works

The past, the present and future of the OK-432 therapy for patients with malignant effusions.

Katano, M., & Morisaki, T. (1998) · PubMed · Cited by 52 · see citing works

Serum Th1 and Th2 cytokine balance in patients of superficial transitional cell carcinoma of bladder pre- and post-intravesical combination immunotherapy

Agarwal, A., Agrawal, U., Verma, S. M., Mohanty, N. K., & Saxena, S. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903300151 · Cited by 49 · see citing works

Re-implantation of tumour tissue treated by cryotreatment with liquid nitrogen induces anti-tumour activity against murine osteosarcoma

Nishida, H., Tsuchiya, H., & Tomita, K. (2008) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.90b9.20671 · Cited by 47 · see citing works

Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton

Matsumoto, M., Seya, T., Kikkawa, S., Tsuji, S., Shida, K., Nomura, M., Kurita-Taniguchi, M., Ohigashi, H., Yokouchi, H., Takami, H., et al. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00071-6 · Cited by 45 · see citing works

Cryoimmunologic Antitumor Effects Enhanced by Dendritic Cells in Osteosarcoma

Kawano, M., Nishida, H., Nakamoto, Y., Tsumura, H., & Tsuchiya, H. (2010) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-010-1302-z · Cited by 32 · see citing works

Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised “proof-of-principle” phase II study

Rosa, F. D., Ridolfi, L., Ridolfi, R., Gentili, G., Valmorri, L., Nanni, O., Petrini, M., Fiammenghi, L., Granato, A. M., Ancarani, V., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-209 · Cited by 28 · see citing works

Efficient generation of highly immunocompetent dendritic cells from peripheral blood of patients with hepatitis C virus-related hepatocellular carcinoma

Kitahara, M., Mizukoshi, E., Nakamoto, Y., Mukaida, N., Matsushima, K., & Kaneko, S. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.05.023 · Cited by 7 · see citing works

Dendritic cell biology and its role in tumor immunotherapy

Wang, Y., Xiang, Y., Xin, V. W., Wang, X.-W., Peng, X., Liu, X., Wang, D., Li, N., Cheng, J.-T., Lyv, Y.-N., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00939-6 · Cited by 456 · see citing works

Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment

Saxena, M., & Bhardwaj, N. (2018) · Trends in cancer · doi:10.1016/j.trecan.2017.12.007 · Cited by 305 · see citing works

Antitumour dendritic cell vaccination in a priming and boosting approach

Harari, A., Graciotti, M., Bassani‐Sternberg, M., & Kandalaft, L. E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0074-8 · Cited by 271 · see citing works

Advances on immunotherapy for osteosarcoma

Yu, S., & Yao, X. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02105-9 · Cited by 270 · see citing works

Osteosarcoma: A comprehensive review of management and treatment strategies

Jafari, F., Javdansirat, S., Sanaie, S., Naseri, A., Shamekh, A., Rostamzadeh, D., & Dolati, S. (2020) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2020.151654 · Cited by 253 · see citing works

Recent Advances of Cell Membrane‐Coated Nanomaterials for Biomedical Applications

Liu, W., Zou, M., Qin, S., Cheng, Y., Ma, Y., Sun, Y., & Zhang, X. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202003559 · Cited by 227 · see citing works

Immunotherapy for osteosarcoma: Where do we go from here?

Wedekind, M. F., Wagner, L. M., & Cripe, T. P. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27227 · Cited by 153 · see citing works

Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials

Groisberg, R., Hong, D. S., Amini, B., Hess, K. R., Jankú, F., Piha-Paul, S. A., Naing, A., Fu, S., Benjamin, R. S., PATEL, S. R., et al. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0301-y · Cited by 148 · see citing works

Trial watch: dendritic cell vaccination for cancer immunotherapy

Sprooten, J., Ceusters, J., Coosemans, A., Agostinis, P., Vleeschouwer, S. D., Zitvogel, L., Kroemer, G., Galluzzi, L., & Garg, A. D. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1638212 · Cited by 148 · see citing works

Recent and Ongoing Research into Metastatic Osteosarcoma Treatments

Harris, M. A., & Hawkins, C. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073817 · Cited by 143 · see citing works

Current and Emerging Targets in Immunotherapy for Osteosarcoma

Miwa, S., Shirai, T., Yamamoto, N., Hayashi, K., Takeuchi, A., Igarashi, K., & Tsuchiya, H. (2019) · Journal of Oncology · doi:10.1155/2019/7035045 · Cited by 123 · see citing works

Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103 ⁺ conventional dendritic cells

Zhou, Y., Slone, N., Chrisikos, T. T., Kyrysyuk, O., Babcock, R. L., Medik, Y. B., Li, H. S., Kleinerman, E. S., & Watowich, S. S. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000474 · Cited by 112 · see citing works

Systemic Treatment for Adults with Synovial Sarcoma

Desar, I. M. E., Fleuren, E. D. G., & van der Graaf, W. T. A. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0525-1 · Cited by 102 · see citing works

Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas

Dancsok, A. R., Setsu, N., Gao, D., Blay, J., Thomas, D. M., Maki, R. G., Nielsen, T. O., & Demicco, E. G. (2019) · Modern Pathology · doi:10.1038/s41379-019-0312-y · Cited by 101 · see citing works

Emerging Targeted and Immune-Based Therapies in Sarcoma

Pollack, S. M., Ingham, M. A., Spraker, M. B., & Schwartz, G. K. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.1610 · Cited by 94 · see citing works

Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression

Fan, T. M., Roberts, R. D., & Lizardo, M. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00013 · Cited by 90 · see citing works

Role of Immunotherapy in the Treatment of Cancer: A Systematic Review

Ling, S. P., Ming, L. C., Dhaliwal, J. S., Gupta, M., Ardianto, C., Goh, K. W., Hussain, Z., & Shafqat, N. (2022) · Cancers · doi:10.3390/cancers14215205 · Cited by 87 · see citing works

The current clinical landscape of personalized cancer vaccines

Fritah, H., Rovelli, R., Chiang, C. L.-L., & Kandalaft, L. E. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102383 · Cited by 87 · see citing works

Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma

Wang, Z., Wang, Z., Li, B., Wang, S., Chen, T., & Ye, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01114 · Cited by 76 · see citing works

Immunotherapy for sarcomas: new frontiers and unveiled opportunities

Birdi, H. K., Jirovec, A., Cortés-Kaplan, S., Werier, J. A., Nessim, C., Diallo, J., & Ardolino, M. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001580 · Cited by 66 · see citing works

Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies

Ji, Z., Shen, J., Lan, Y., Yi, Q., & Liu, H. (2023) · MedComm · doi:10.1002/mco2.308 · Cited by 68 · see citing works

Osteosarcoma: Current Concepts and Evolutions in Management Principles

Pilavaki, P., Ardakani, A. H. G., Gikas, P. D., & Constantinidou, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082785 · Cited by 70 · see citing works

Therapeutic Targets for Bone and Soft-Tissue Sarcomas

Miwa, S., Yamamoto, N., Hayashi, K., Takeuchi, A., Igarashi, K., & Tsuchiya, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010170 · Cited by 65 · see citing works

cDC1 Vaccines Drive Tumor Rejection by Direct Presentation Independently of Host cDC1

Ferris, S. T., Ohara, R. A., Ou, F., Wu, R., Huang, X., Kim, S. K., Chen, J., Liu, T., Schreiber, R. D., Murphy, T. L., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0865 · Cited by 60 · see citing works

Bone sarcomas in the immunotherapy era

Heymann, M., Schiavone, K., & Heymann, D. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14999 · Cited by 57 · see citing works

Novel Immunotherapies for Osteosarcoma

Lu, Y., Zhang, J., Chen, Y., Kang, Y., Liao, Z., He, Y., & Zhang, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.830546 · Cited by 56 · see citing works

Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas

Nakano, K., & Takahashi, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030739 · Cited by 53 · see citing works

Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness

Panagi, M., Pilavaki, P., Constantinidou, A., & Stylianopoulos, T. (2022) · Theranostics · doi:10.7150/thno.72800 · Cited by 55 · see citing works

Checkpoint Blockade in Combination With Doxorubicin Augments Tumor Cell Apoptosis in Osteosarcoma

Wang, J., Hu, C., Wang, J., Shen, Y., Bao, Q., He, F., Wang, H., Gong, L., Liu, Z., Hu, F., et al. (2019) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000281 · Cited by 46 · see citing works

Chemotherapy, immunotherapy, and targeted therapy for osteosarcoma: Recent advancements

Adewuyi, E. E., Chorya, H. P., Muili, A. O., Moradeyo, A. A., Kayode, A. T., Naik, A., Odedele, J. T., & Obasanjo, O. M. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104575 · Cited by 42 · see citing works

Immune Landscape of the Tumor Microenvironment Identifies Prognostic Gene Signature CD4/CD68/CSF1R in Osteosarcoma

Song, Y., Xu, Y., Zhu, X., Fu, J., Deng, C., Chen, H., Xu, H., Song, G., Lu, J., Tang, Q., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01198 · Cited by 40 · see citing works

A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy

Pan, R., Pan, F., Zeng, Z., Lei, S., Yang, Y., Yang, Y., Hu, C., Chen, H., & Tian, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1017120 · Cited by 38 · see citing works

Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma

Yan, P., Wang, J., Yue, B., & Wang, X. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189171 · Cited by 31 · see citing works

Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies

Liang, H., Cui, M., Tu, J., & Chen, X. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1394339 · Cited by 30 · see citing works

Advances and challenges in the treatment of osteosarcoma

Wang, X., Zhu, K., Hu, J., & Zhang, C. (2025) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2025.07.001 · Cited by 31 · see citing works

Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy

Sousa, L. M., Almeida, J. S., Fortes-Andrade, T., Santos-Rosa, M., Freitas-Tavares, P., Casanova, J., & Rodrigues‐Santos, P. (2021) · Cancers · doi:10.3390/cancers13153885 · Cited by 26 · see citing works

Immunotherapy of osteosarcoma based on immune microenvironment modulation

Lian, H., Zhang, J., Hou, S., Ma, S., Yu, J., Zhao, W., Zhao, D., & Zhang, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1498060 · Cited by 24 · see citing works

Immune checkpoint inhibitors in sarcomas: a systematic review

Anastasiou, Μ., Kyriazoglou, A. I., Kotsantis, I., Economopoulou, P., Kyrkasiadou, M., Giannopoulou, A. E., Kosmidou, A., Smerdi, D., Moutafi, M. K., Gavrielatou, N., et al. (2023) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2023.100407 · Cited by 24 · see citing works

Biomaterials‐Boosted Immunotherapy for Osteosarcoma

Sun, C., Li, S., & Ding, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400864 · Cited by 23 · see citing works

A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?

van Ewijk, R., Cleirec, M., Herold, N., le Deley, M.-C., van Eijkelenburg, N., Boudou-Rouquette, P., Risbourg, S., Strauss, S. J., Palmerini, E., Boye, K., et al. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102625 · Cited by 19 · see citing works

Reviewing the significance of dendritic cell vaccines in interrupting breast cancer development

Gautam, N., Ramamoorthi, G., Champion, N., Han, H. S., & Czerniecki, B. J. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101239 · Cited by 19 · see citing works

Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights

Zhang, Y., Jiang, S., Lv, J., Feng, W., Yu, Y., & Zhao, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584450 · Cited by 22 · see citing works

Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas

Yeagley, M. G., Chobrutskiy, B. I., Gozlan, E. C., Medikonda, N., Patel, D. N., Falasiri, S. S. A., Callahan, B. M., Huda, T. I., & Blanck, G. (2021) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2020.1843576 · Cited by 18 · see citing works

Exploring the landscape of immunotherapy approaches in sarcomas

Pilavaki, P., Panagi, M., Arifi, S., Jones, R. L., Stylianopoulos, T., & Constantinidou, A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1069963 · Cited by 17 · see citing works

Vx3-Functionalized Alumina Nanoparticles Assisted Enrichment of Ubiquitinated Proteins from Cancer Cells for Enhanced Cancer Immunotherapy

Zhao, J., Pan, N., Huang, F., Aldarouish, M., Wen, Z., Gao, R., Zhang, Y., Hu, H., Shen, Y., & Wang, L. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00578 · Cited by 17 · see citing works

Current Status of Immunotherapy for Sarcomas

Miwa, S., Nishida, H., & Tsuchiya, H. (2017) · Immunotherapy · doi:10.2217/imt-2017-0101 · Cited by 16 · see citing works

Applying Osteosarcoma Immunology to Understand Disease Progression and Assess Immunotherapeutic Response

Pratt, H. G., Justin, E. M., & Lindsey, B. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_6 · Cited by 16 · see citing works

Translational oncotargets for immunotherapy: From pet dogs to humans

Mestrinho, L. A., & Santos, R. R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.020 · Cited by 16 · see citing works

Role of immunotherapy in chondrosarcoma: A case report and review of the literature

Cohen-Nowak, A. J., Dressler, D. B., Rock, A., Mojica, K., Woo, D., Zuckerman, L. M., Chow, W., & Agulnik, M. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231199877 · Cited by 16 · see citing works

A Review of T-Cell Related Therapy for Osteosarcoma

Yoshida, K., Okamoto, M., Aoki, K., Takahashi, J., & Saito, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144877 · Cited by 14 · see citing works

Current treatment landscape and emerging management options for extremity sarcoma

Turkar, S. (2018) · Cancer Research Statistics and Treatment · doi:10.4103/crst.crst_9_19 · Cited by 13 · see citing works

CD103+ cDC1 Dendritic Cell Vaccine Therapy for Osteosarcoma Lung Metastases

Yang, Y., Zhou, Y., Wang, J., Zhou, Y. L., Watowich, S. S., & Kleinerman, E. S. (2024) · Cancers · doi:10.3390/cancers16193251 · Cited by 12 · see citing works

Emerging immunotherapy and tumor microenvironment for advanced sarcoma: a comprehensive review

Huang, H. W., Fan, Y., Zhang, S., Bai, X., Wang, X., & Shan, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1507870 · Cited by 13 · see citing works

Irreversible Electroporation Combined With Dendritic Cell-based Vaccines for the Treatment of Osteosarcoma

Sun, C., MA, X., ZHOU, C., Zhang, Z., & GUO, J. (2023) · Anticancer Research · doi:10.21873/anticanres.16514 · Cited by 10 · see citing works

Emerging mechanisms of immunotherapy resistance in sarcomas

Florou, V., & Wilky, B. A. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.111 · Cited by 10 · see citing works

Linking Immunity with Genomics in Sarcomas: Is Genomic Complexity an Immunogenic Trigger?

van Oost, S., Meijer, D. M., Kuijjer, M. L., Bovée, J. V. M. G., & de Miranda, N. F. C. C. (2021) · Biomedicines · doi:10.3390/biomedicines9081048 · Cited by 9 · see citing works

Efficacy and Safety of Treating Refractory Bone and Soft Tissue Sarcoma with Anlotinib in Different Treatment Patterns

Cai, M., Zhu, J., & Zhou, G. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/3287961 · Cited by 9 · see citing works

Clinical effect and safety of dendritic cell–cytokine-induced killer cell immunotherapy for pancreatic cancer: a systematic review and meta-analysis

Liu, Y., Yang, L., Zhang, F., Tang, B.-S., Zhao, L., Zhu, J.-R., Jin, Q., Wang, R., & Li, Y. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2019.07.006 · Cited by 8 · see citing works

Emerging Trends in Immunotherapy for Adult Sarcomas

Husain, M., Chen, L., Liebner, D. A., Beane, J. D., Rubinstein, M. P., Pollock, R. E., Verschraegen, C. F., & Tinoco, G. (2023) · The Oncologist · doi:10.1093/oncolo/oyad052 · Cited by 7 · see citing works

The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov

Que, Y., Xiao, W., Xu, B., Wen, X., Weng, D., & Zhang, X. (2018) · BMC Cancer · doi:10.1186/s12885-018-5163-2 · Cited by 7 · see citing works

Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma

Han, S., Wang, Q., Shen, M., Zhang, X., & Wang, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27630 · Cited by 6 · see citing works

EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma Based on an Integrative Analysis

Dai, Z., Liu, Z., Yang, R., Cao, W., & Ji, T. (2023) · Biomolecules · doi:10.3390/biom13020327 · Cited by 7 · see citing works

Allogenic γδ T cell and tumor cell fused vaccine for enhanced immunotherapeutic efficacy of osteosarcoma

Wang, Y., Zhu, J., Yu, W., Wang, J., Xia, K., Liang, C., & Tao, H. (2018) · Journal of bone oncology · doi:10.1016/j.jbo.2018.100214 · Cited by 6 · see citing works

Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit?

Chew, H. Y., Chan, V., Simpson, F., & Dolcetti, R. (2020) · Cancers · doi:10.3390/cancers12113392 · Cited by 6 · see citing works

Potential of immunotherapy for sarcoma

Hoffman, R. M., Singh, A. S., & Eilber, F. C. (2017) · Cancer · doi:10.1002/cncr.30603 · Cited by 6 · see citing works

Emerging innovations and advancements in the treatment of extremity and truncal soft tissue sarcomas

Walker, K. E., Simister, S. K., Carr, J. R., Monument, M. J., Thorpe, S. W., & Randall, R. L. (2023) · Journal of Surgical Oncology · doi:10.1002/jso.27526 · Cited by 5 · see citing works

Influence of higher body mass index on postoperative nausea and vomiting in patients following thoracic surgery for lung cancer: a propensity score-matched cohort study

Zhang, N., Feng, D., Wu, W., Liu, J. T., & Shi, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-64686-1 · Cited by 4 · see citing works

In VitroGeneration of Anti-Osteosarcoma Cytotoxic Activity Using Dendritic Cells Loaded with Heat Shock Protein 70-Peptide Complexes

Li, Y., Wang, D., & Fang, X. (2019) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2019.1600624 · Cited by 4 · see citing works

Associations of PD-L1, PD-L2, and HLA class I expression with responses to immunotherapy in patients with advanced sarcoma: post hoc analysis of a phase 1/2 trial

Miwa, S., Nojima, T., Alomesen, A., Ikeda, H., Yamamoto, N., Nishida, H., Hayashi, K., Takeuchi, A., Igarashi, K., Higuchi, T., et al. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02559-z · Cited by 3 · see citing works

The lung pre‐metastatic niche in osteosarcoma: Mechanism and therapeutic intervention

Wang, D., Liu, T., Yin, B., Chang, Y., Hyon-U, P., Zhang, Y., & Li, H. (2025) · International Journal of Cancer · doi:10.1002/ijc.70188 · Cited by 2 · see citing works

Advances in T cell–based immunotherapy for osteosarcoma

Zhang, K., Wang, Z., He, J., Lu, L., Wang, W., Yang, A., Xie, H., Huang, L., Huang, Y., Zhang, K., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1769847 · Cited by 3 · see citing works

Macrophage plasticity in the osteosarcoma tumor microenvironment: opportunities and challenges for immunotherapy

Li, H., Liu, C., Zhang, B., Zhang, Y., & Liu, Y. (2026) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-026-06471-3 · Cited by 2 · see citing works

Immune Cell Vaccine for Cancer

Razi, S., & Rezaei, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814039-0.00009-6 · Cited by 2 · see citing works

Primary Pleuropulmonary Synovial Sarcoma: Report of Two Cases and a Comprehensive Review of the Literature

Khalili, N., Askari, E., Khalili, N., Daneshvar-Kakhki, A., Sadr, M., Haseli, S., & Toutkaboni, M. P. (2021) · Cancer Investigation · doi:10.1080/07357907.2021.2001484 · Cited by 2 · see citing works

Immunotherapy of Osteosarcoma

Sorteberg, A. L., Ek, L., Lilienthal, I., & Herold, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_236-1 · Cited by 2 · see citing works

Fabrication of Micro-Nano Bioactive Glass Scaffold Incorporated with Siglec-15 for Bone Repair and Postoperative Treatment of Osteosarcoma

Li, X., Yan, C., Wang, D., Lu, H., & Xia, Z. (2021) · Science of Advanced Materials · doi:10.1166/sam.2021.4000 · Cited by 2 · see citing works

Breast cancer treatment by transplantations of dendritic cells and cytokine-induced killer cells: An update on clinical trials

Ngo, H. T., & Phamb, P. V. (2021) · Biomedical Research and Therapy · doi:10.15419/bmrat.v8i11.707 · Cited by 2 · see citing works

Immunogenicity of neoantigens: From CAR-T cell to various vaccines

Davodabadi, F., Arabpour, J., Goleij, P., Mohammadi, E., Taheri, M., Sethi, G., Dua, K., & Sarhadi, M. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125924 · Cited by 1 · see citing works

Immunotherapy of Osteosarcoma

Sorteberg, A. L., Ek, L., Lilienthal, I., & Herold, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00769-8_236 · Cited by 1 · see citing works

Regulatory mechanisms and functions of RORγt⁺ antigen-presenting cells in the tumor microenvironment of non-small cell lung cancer

Tan, Q., Zhang, W., Wang, Y., Wang, H., Guo, R., Zhu, H., Ying, D., Li, Y., Li, X., & Song, J. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105142 · Cited by 1 · see citing works

Sex and dendritic cell vaccination performance in cancer—so what difference does it make? A review and meta-analysis

Nguyen, Q. D. K., Brennan, D., & Bennett, J. (2026) · Research Connections · doi:10.1093/rescon/vmag110 · Cited by 1 · see citing works

Chondrosarcoma of the Appendicular Skeleton

Geiger, E. J., & Bernthal, N. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-74572-1_7 · Cited by 1 · see citing works

Biological reconstruction after tumor resection

Tsuchiya, H. (2018) · Journal of Limb Lengthening & Reconstruction · doi:10.4103/jllr.jllr_9_18

Global Research on Osteosarcoma, 1999–2019: A Bibliometric and Visual AnalysisPreprint

Wu, H. J., Wei, B., Cheng, Y., & Li, Y. (2020) · doi:10.21203/rs.3.rs-19452/v1

Monitoring the Systemic Immune System to Understand and Improve the Efficacy of Immunotherapy for Metastatic Osteosarcoma

Markel, J. (2020) · doi:10.33915/etd.7770

Global Research on Osteosarcoma, 1999–2019: A Bibliometric and Visual AnalysisPreprint

Zhang, J., Li, Y., & Wu, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2197001/v1

Immunotherapy for Sarcoma

Pilavaki, P., & Constantinidou, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_235-1

Special Issue: “Pediatric Orthopedic Malignancy: Types, Symptoms, and Treatment”

Aiba, H., Miwa, S., Murakami, H., & Kimura, H. J. (2023) · Children · doi:10.3390/children10091545

Effects of Injectable Solutions on the Quality of Monocyte‐Derived Dendritic Cells for Immunotherapy

da Silva, L. T., Tiyo, B. T., Mota, S. D. J., Ortega, M. M., Schmitz, G. J. H., Taniwaki, N. N., Namiyama, G. M., Duarte, A. J. D. S., & Oshiro, T. M. (2024) · Journal of Immunology Research · doi:10.1155/2024/6817965

Immunotherapy for Sarcoma

Pilavaki, P., & Constantinidou, A. (2025) · Springer eBooks · doi:10.1007/978-3-032-00769-8_235

Harnessing the immune system against osteosarcoma: from tumor microenvironment modulation to combinatorial immunotherapies

Duan, L. L., Zhu, H., Chen, C., & Liu, W. (2026) · Holistic Integrative Oncology · doi:10.1007/s44178-026-00226-3

Utilisation de miRNAs thérapeutiques pour traiter les chondrosarcomes et les ostéosarcomes

Veys, C. (2021) · theses.fr (ABES) · doi:10.70675/7a59188ez7981z4d53za4fdz22a6b5deaaad

Reprogramming dendritic cells to overcome tumor-mediated immune suppression

Malik, J. A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1844446

Clinical efficacy and safety outcomes of anlotinib therapy in sarcoma: a systematic review and meta-analysis

Matar, H. I., Melhem, A., Shawwa, A., Yousef, T., Alananbeh, M., Alsalim, E., -Refai, E. A., Abuhwaij, M., & Elayan, D. (2026) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-026-00384-5

Clinical development landscape of CAR/TCR-engineered cellular therapies in musculoskeletal sarcomas: a TrialTrove-based registry analysis

Jia, X., Chen, Q., Wang, Y., He, Y., Wang, J., & Yan, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1939952

Dendritic cells immunotherapy for patients with malignant bone and soft tissue tumors.

Nishida, H., Yamamoto, N., Takeuchi, A., Kimura, H. J., Shimozaki, S., Kato, T., Aoki, Y., Igarashi, K., Higuchi, T., & Tsuchiya, H. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.10539

Results of a Pilot Trial of Immunotherapy with Dendritic Cells Pulsed with Autologous Tumor Lysates in Patients with Advanced Cancer

Mayordomo, J. I., Andrés, R., Isla, M. D., Murillo, L. S., Cajal, R., Yubero, A., Blasco, C., Lasierra, P., Palomera, L., Fuertes, M. A., et al. (2007) · Tumori Journal · doi:10.1177/030089160709300106 · Cited by 14 · see citing works

Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma.

Dhir, A., Koru‐Sengul, T., Grosso, J., D’Amato, G. Z., Trucco, M. M., Rosenberg, A. E., Gilboa, E., Goldberg, J. M., Trent, J. C., & Wilky, B. A. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.15_suppl.11542 · Cited by 4 · see citing works

Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care

Bapsy, P. P., Sharan, B., Kumar, C., Das, R. P., Rangarajan, B., Jain, M. M., Attili, V. S. S., Subramanian, S., Aggarwal, S., Srivastava, M., et al. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2013.11.013 · Cited by 46 · see citing works

TNF-a and Tumor Lysate Promote the Maturation of Dendritic Cells for Immunotherapy for Advanced Malignant Bone and Soft Tissue Tumors

Miwa, S., Nishida, H., Tanzawa, Y., Takata, M., Takeuchi, A., Yamamoto, N., Shirai, T., Hayashi, K., Kimura, H., & Igarashi, K. (2016)